12 Aug Leon Nanodrugs
leon-nanodrugs GmbH specializes in the development of equipment for the encapsulation of genetic material and other pharmaceutical active substances into nanocarriers, such as lipid nanoparticles (LNPs). The company leverages its proprietary FR-JET® technology to build innovative solutions. Its equipment portfolio includes NANOscreen® for formulation screening, NANOlab® for process development, as well as NANOme® and NANOus® for GMP manufacture. These systems are suitable for both individualized scales and large-scale commercial production. LEON’s platform solves scale-up unpredictability with consistent mixing from lab to GMP scale, cutting re-optimization and CMC disruption risk. The real cost of that unpredictability isn’t lost materials – it’s lost time: delayed process lock, slipped clinical milestones, and a lower product NPV. leon-nanodrugs GmbH (LEON) specializes in the development of equipment for the encapsulation of genetic material and other pharmaceutical active substances into nanocarriers, such as lipid nanoparticles (LNPs). The company leverages its proprietary FR-JET® technology to build innovative solutions. Its equipment portfolio includes NANOscreen® for formulation screening, NANOlab® for process development, as well as NANOme® and NANOus® for GMP manufacture.